Barely Significant
← all excerpts

Treatment outcome of flow-diversion with Surpass Evolve stent for unruptured intracranial aneurysms: Predictors of poor occlusion.

J Cerebrovasc Endovasc Neurosurg · 2026 · PMC13053130 · PMID 41093598

Europe PMCDOI
2
hedged sentences
0.1230
closest p · 2.5× alpha
0.1230
boldest claim

The sentences

did not reach statistical significancep=0.123not close (p > 0.1)
Age and previous treatment history did not reach statistical significance in the adjusted model (age: OR 0.95; p=0.123; previous treatment: OR 2.55; p=0.293, respectively).

also in 111,027 other papers

a negative trendno p-value reported
On the other hand, although the SEASE (Safety and Effectiveness Assessment of the Surpass Evolve) trial did not reach statistical significance (p=0.06) between larger aneurysm (≥10 mm) and aneurysm occlusion, they demonstrated a negative trend toward lower complete occlusion rates [ 31 ].

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.